- Home
- RBB vs ORGO Comparison
RBB vs ORGO Comparison
Compare RBB & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RBB | ORGO |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | 369 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.9M | 348.6M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RBB | ORGO |
|---|---|---|
| Price | $23.73 | $2.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.00 | $8.50 |
| AVG Volume (30 Days) | 73.1K | ★ 1.3M |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | 24.49 | ★ 1600.00 |
| EPS | ★ 0.66 | N/A |
| Revenue | $5,167,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $20.50 | N/A |
| Revenue Next Year | $6.90 | $26.27 |
| P/E Ratio | $35.79 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $15.95 | $2.04 |
| 52 Week High | $24.73 | $7.08 |
Technical Indicators
Market Signals| Indicator | RBB | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 54.54 |
| Support Level | $20.11 | $2.21 |
| Resistance Level | $24.72 | $2.66 |
| Average True Range (ATR) | 0.51 | 0.19 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 36.22 | 75.84 |
Price Performance
Historical ComparisonAbout RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.